Lazard SF Healthcare or Citi NYC

I'm a sophomore at Stanford interested in IB. A lot of my background is in healthcare and biotech, and I'm very interested in the field, but going to New York is also a plus/consideration for me. What are you're guys' thoughts?

 

Neither. Hold out for better to come in the fall. Given your background probably every finance job in the Bay Area would be an option and there are a lot of PE/VC type firms that take undergrads too. Think of all the truly elite sophomores at Wharton and whatnot who have already signed with EBs. The competition for what remains will be relatively low.

"Truth is like poetry. And most people fucking hate poetry."
 

Jeez just a thought but cmon odds are this guy holds out and gets a more prestigious role at say JPM HC, BAML HC, Centerview HC, GS/MS tech or god forbid on the buy side. In these options you could be in NYC at a place a distinct step above Citi. Not sure why someone at Stanford who is clearly on top of their shit would cave this early. It’s not even PJT/EVR. If either agreed Lazard.

"Truth is like poetry. And most people fucking hate poetry."
 

If you're 100% set on Healthcare/Biotech, SF is definitely the place to be in my opinion.

Both are great options but there's no guarantee you'll be doing HC at Citi so that might be something to consider.

On a separate note, if you do get the chance, definitely take a look at Centerview's Healthcare/Biotech practice. They have a very solid team out in SF and it's certainly worth the look.

 

Your top priority should be fit with the team. By far.

Then, you should consider this: NY typically covers everything (biotech, services, medtech) while SF typically covers biotech (or biotech and medtech). So by choosing a city, your experience will vary.

Equally important to the above, try NYC if you are that eager. But if you're curious but not eager, not as much of a biggie.

You're just doing an internship so pigeonholing yourself is not a concern.

 

Saepe ea voluptatibus perferendis libero totam. Quas perspiciatis ut necessitatibus sint. Assumenda culpa minima harum adipisci doloribus qui.

Soluta ad illo deserunt natus ut qui eveniet. Voluptatem expedita deleniti dolor. Nihil voluptas velit in.

Dolores dolores est enim officia vero recusandae impedit. Est accusantium sed sint numquam dolorem aliquid blanditiis. Quidem unde alias omnis doloribus. Unde ut tempore ipsum atque alias est.

Career Advancement Opportunities

May 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. New 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 04 97.1%

Overall Employee Satisfaction

May 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

May 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

May 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (88) $260
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (67) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (146) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Betsy Massar's picture
Betsy Massar
99.0
5
kanon's picture
kanon
98.9
6
CompBanker's picture
CompBanker
98.9
7
dosk17's picture
dosk17
98.9
8
GameTheory's picture
GameTheory
98.9
9
bolo up's picture
bolo up
98.8
10
DrApeman's picture
DrApeman
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”